Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer.
Thomas Eldridge StinchcombePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)